ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998

NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2

November 23, 1990

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution

April 12, 1985

In Brief: Margaret Holms Names Centers Branch Chief; Kimes To Recruit As Special Assistant

March 30, 1990

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010